Repurposing of GFE for Novel Drug Delivery Platforms

The contract seeks to redesign and adapt government-furnished emergency autoinjector manufacturing equipment to support a novel drug delivery platform that utilizes film-based collapsible containers, replacing traditional rigid packaging with a more advanced, lightweight, and potentially more efficient system. This effort involves modifying existing machinery originally designed for autoinjector production to accurately and reliably handle the unique physical and structural properties of film-based containers, requiring significant engineering adaptations in filling, sealing, and assembly processes while maintaining regulatory compliance and production integrity. The work is critical for transitioning current emergency drug delivery capabilities into a next-generation platform with improved storage, transport, and usability characteristics. This subcontract opportunity, posted under NAICS code 541330 by the Department of Health and Human Services through Barda - ASPR/DAAPPO/Barda DCMA, is open for responses until July 23, 2026, with performance centered in Washington. The project demands specialized expertise in pharmaceutical manufacturing equipment reconfiguration, materials science related to film-based containers, and familiarity with federal medical countermeasure standards. Bidders must demonstrate technical capability to execute the modifications without disrupting supply chain continuity, ensure product sterility and dosing accuracy, and align with any applicable federal quality and safety guidelines. The goal is to modernize production infrastructure to enable scalable, cost-effective deployment of next-generation emergency therapeutics.